Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals
Martínez del Prado, Purificación, Alvarez-López, Isabel, Domínguez-Fernández, Severina, Plazaola, Arrate, Ibarrondo, Oliver, Galve-Calvo, Elena, Ancizar-Lizarraga, Nerea, Gutierrez-Toribio, María, LahVolume:
Volume 10
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S146095
Date:
March, 2018
File:
PDF, 293 KB
english, 2018